We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
38 hedge funds and large institutions have $797K invested in Cardiff Oncology in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.13% less ownership
Funds ownership: 0.2% → 0.07% (-0.13%)
19% less funds holding
Funds holding: 47 → 38 (-9)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
79% less capital invested
Capital invested by funds: $3.84M → $797K (-$3.04M)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
38
Holders Change
-9
Holders Change %
-19.15%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
13
Closed
9
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$2K
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$35.3K |
| 2 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
+$9.83K |
| 3 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
+$1.73K |
| 4 |
Bank of New York Mellon
New York
|
+$1.28K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.02K |
